GLP1 agonists are important but not a replacement to address all the components in society that contribute to obesity including ultra processed food, sedentary living, added sugar and sugar substitutes, etc.

This is a really good summary of the major medical advances in 2025. Puts a positive note when we sit back and reflect on what we gained in knowledge in 2025.

Thank you for sharing our article. Body mass index is an imprecise measure to assess fat at an individual level. New obesity definitions try to characterize the impacts of fat on your physical, metabolic, and daily life.